TEL/AML1 t(12;21)-ALL

Description:

This test is useful in cases of Acute Lymphoblastic Leukemia (ALL) with a suspected TEL/AML translocation. A chimeric product is formed as a result of translocation between the the helix-loop-helix domain of TEL on chromosome 12 fused to AML-1 (RUNX1) gene on chromosome 21, the DNA-binding subunit of the AML-1/CBF beta transcription factor complex. The fused protein formed gives rise to ALL. The test can help in detection of this particular defect using FISH technique.

Technique:

Flourescent in Situ Hybridization

Specialities:

Oncology, Clinical hematology, Medicine

Indications:

Hematological Maligancy

TAT:

3 days

Specimen Requirements:

Bone Marrow/Peripheral Blood in green top (Na-Heparin tube) 3-4 ml

Test Code:

2212

Quick Links

Maternal / Prenatal Screening

Pre-eclampsia Screening and Diagnosis

Prenatal Diagnosis

Non Invasive Prenatal Screening (NIPS)